Business Description
Rakovina Therapeutics Inc
NAICS : 541714
SIC : 3741
ISIN : CA75103L1013
Description
Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some f its products in the pipeline include kt-2000 AI, kt-3000 series.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | -0.69 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.85 | |||||
9-Day RSI | 42.86 | |||||
14-Day RSI | 43.74 | |||||
6-1 Month Momentum % | 33.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -63.96 | |||||
ROA % | -49.42 | |||||
ROIC % | -53.25 | |||||
ROC (Joel Greenblatt) % | -1877.9 | |||||
ROCE % | -47.15 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.14 | |||||
EV-to-EBIT | -3.71 | |||||
EV-to-EBITDA | -4.72 | |||||
EV-to-FCF | -5.27 | |||||
Earnings Yield (Greenblatt) % | -26.96 | |||||
FCF Yield % | -22.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rakovina Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.04 | ||
Beta | 0.07 | ||
Volatility % | 79.25 | ||
14-Day RSI | 43.74 | ||
14-Day ATR (C$) | 0.0064 | ||
20-Day SMA (C$) | 0.09325 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (C$) | 0.005 - 0.135 | ||
Shares Outstanding (Mil) | 90.29 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rakovina Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rakovina Therapeutics Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Rakovina Therapeutics Inc Frequently Asked Questions
What is Rakovina Therapeutics Inc(TSXV:RKV)'s stock price today?
The current price of TSXV:RKV is C$0.09. The 52 week high of TSXV:RKV is C$0.14 and 52 week low is C$0.01.
When is next earnings date of Rakovina Therapeutics Inc(TSXV:RKV)?
The next earnings date of Rakovina Therapeutics Inc(TSXV:RKV) is .
Does Rakovina Therapeutics Inc(TSXV:RKV) pay dividends? If so, how much?
Rakovina Therapeutics Inc(TSXV:RKV) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |